Effects of Prehospital Epinephrine During Out-of-hospital Cardiac Arrest with Initial Non-shockable Rhythm: an Observational Cohort Study
Overview
Authors
Affiliations
Introduction: Few clinical trials have provided evidence that epinephrine administration after out-of-hospital cardiac arrest (OHCA) improves long-term survival. Here we determined whether prehospital epinephrine administration would improve 1-month survival in OHCA patients.
Methods: We analyzed the data of 209,577 OHCA patients; the data were prospectively collected in a nationwide Utstein-style Japanese database between 2009 and 2010. Patients were divided into the initial shockable rhythm (n = 15,492) and initial non-shockable rhythm (n = 194,085) cohorts. The endpoints were prehospital return of spontaneous circulation (ROSC), 1-month survival, and 1-month favorable neurological outcomes (cerebral performance category scale, category 1 or 2) after OHCA. We defined epinephrine administration time as the time from the start of cardiopulmonary resuscitation (CPR) by emergency medical services personnel to the first epinephrine administration.
Results: In the initial shockable rhythm cohort, the ratios of prehospital ROSC, 1-month survival, and 1-month favorable neurological outcomes in the non-epinephrine group were significantly higher than those in the epinephrine group (27.7% vs. 22.8%, 27.0% vs. 15.4%, and 18.6% vs. 7.0%, respectively; all P < 0.001). However, in the initial non-shockable rhythm cohort, the ratios of prehospital ROSC and 1-month survival in the epinephrine group were significantly higher than those in the non-epinephrine group (18.7% vs. 3.0% and 3.9% vs. 2.2%, respectively; all P < 0.001) and there was no significant difference between the epinephrine and non-epinephrine groups for 1-month favorable neurological outcomes (P = 0.62). Prehospital epinephrine administration for OHCA patients with initial non-shockable rhythms was independently associated with prehospital ROSC (adjusted odds ratio [aOR], 8.83, 6.18, 4.32; 95% confidence interval [CI], 8.01-9.73, 5.82-6.56, 3.98-4.69; for epinephrine administration times ≤9 min, 10-19 min, and ≥20 min, respectively), with improved 1-month survival when epinephrine administration time was <20 min (aOR, 1.78, 1.29; 95% CI, 1.50-2.10, 1.17-1.43; for epinephrine administration times ≤9 min and 10-19 min, respectively), and with deteriorated 1-month favorable neurological outcomes (aOR, 0.63, 0.49; 95% CI, 0.48-0.80, 0.32-0.71; for epinephrine administration times 10-19 min and ≥20 min, respectively).
Conclusions: Prehospital epinephrine administration for OHCA patients with initial nonshockable rhythms was independently associated with achievement of prehospital ROSC and had association with improved 1-month survival when epinephrine administration time was <20 min.
Hubble M, Taylor S, Martin M, Houston S, Kaplan G Ir J Med Sci. 2024; 193(6):2713-2721.
PMID: 39190288 DOI: 10.1007/s11845-024-03797-0.
Kramser N, Duse D, Grone M, Stucker B, Voss F, Tokhi U J Clin Med. 2024; 13(13).
PMID: 38999496 PMC: 11242294. DOI: 10.3390/jcm13133931.
Chander S, Parkash O, Luhana S, Lohana A, Sadarat F, Sapna F BMC Cardiovasc Disord. 2024; 24(1):283.
PMID: 38816786 PMC: 11137957. DOI: 10.1186/s12872-024-03962-4.
Park S, Choi B, Kim S BMC Emerg Med. 2024; 24(1):79.
PMID: 38710999 PMC: 11071239. DOI: 10.1186/s12873-024-00998-9.
Epinephrine in Cardiac Arrest: Identifying a Potential Limit for Resuscitation.
Boivin Z, Duignan K, Doko D, Pugliese N, She T West J Emerg Med. 2024; 24(6):1025-1033.
PMID: 38165183 PMC: 10754196. DOI: 10.5811/westjem.60840.